10x Capital Venture Acquisition Corp Iii (VCXBU) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket
 


10x Capital Venture Acquisition Corp Iii  (NYSE: VCXBU)


10x Capital Venture Acquisition Iii's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is 10x Capital Venture Acquisition Iii's ROI in the third quarter of 2023?
10x Capital Venture Acquisition Corp Iii recorded a cumulative net loss of $-1 million during 12 months ending in the third quarter of 2023, resulting in a negative return on investment (ROI) of -3.11%.

Within the Healthcare sector 233 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2023 from 1939 to 2890.

Definition and Formula of Return on Investment



Return On Investment (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Investment Change TTM -82.47 % -29.94 % 126.02 % 64479.89 % -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 38 41 42 40 306
Return On Investment (TTM) -3.11 % 2.01 % 2.2 % 0.29 % 0.28 %
VCXBU's Overall Ranking # 2890 # 1939 # 2936 # 0 # 0
Seq. Investment Change TTM -62.46 % -38.17 % -27.5 % 4.15 % 50.05 %
Seq. Net Income Change TTM - -43.7 % 447.17 % 9.24 % -
Net Income (TTM) in Millions -1 2 4 1 1




Return On Investment VCXBU's Ranking
Within: No.
Industry # 25
Sector # 234
Overall # 2890

Return On Investment Statistics
High Average Low
2.2 %
0.19 %
-3.11 %
(Mar 31 2023)   (Sep 30 2023)







Financial Statements
10x Capital Venture Acquisition Iii's III. Quarter Investments $ 38 Millions VCXBU's Balance sheet
10x Capital Venture Acquisition Iii's III. Quarter Income $ -2 Millions Quarterly VCXBU's Income Statement
VCXBU's Income by Division See VCXBU's Income by Division


VCXBU Annual Return On Investment (Dec 31 2022)
2022




Total Investments in Millions 40 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions 1 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 1.77 % - - - -


Annual Roi Comment
In the fiscal year 2022 ROI deteriorated to 1.77 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VCXBU's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VCXBU's Competitors
Subscribers only: Roi for 10x Capital Venture Acquisition Iii's Suppliers
Subscribers only: Return On Investment for VCXBU's Customers

Other Ratios
VCXBU's Roa VCXBU's Inventory Turnover Ratio VCXBU's Growth Rates VCXBU's Dividend Statistics
VCXBU's Profitability Ratios VCXBU's Asset Turnover Ratio VCXBU's Dividend Growth
VCXBU's Roe VCXBU's Valuation Ratios VCXBU's Financial Strength Ratios VCXBU's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI


Date modified: 2026-09-26T07:41:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.